CD274 and neoplasm: By blocking the interaction between tumor cells and immune checkpoints on T cells, such as CTLA-4 or PD-1/PDL1, the break on T cell inhibition is released, enabling activation, proliferation and the release of cytotoxins such as perforin and granzymes that eventually lead to apoptosis of tumor cells (5–7).